Solid phase synthesis of glycopeptide dendrimers with Tn antigenic structure and their biological activities. Part I

Journal of Peptide Science

Volumn 5, Issue 1, 1999, Pages 46-55

  Ježek, Jan ^a   Velek, Jiří ^a   Vepřek, Pavel ^a   Velková, Vlasta ^a   Trnka, Toḿaš ^b   Pecka, Jaroslav ^b   Ledvina, Miroslav ^a   Vondrášek, Jiří ^a   Písačka, Martin ^c  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Glycopeptide dendrimers; Molecular modelling; Multiple antigen glycopeptide systems (MAGs); Solid phase peptide synthesis SPPS); Tn antigens; Tumour associated antigens

Indexed keywords

ANTIGEN; ANTISERUM; DENDRIMER; GLYCOPEPTIDE; MONOCLONAL ANTIBODY; TUMOR VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BLOOD GROUP O; CONJUGATE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; ERYTHROCYTE; FEMALE; IMMUNIZATION; IMMUNOPHARMACOLOGY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 2442752590     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1387(199901)5:1<46::AID-PSC179>3.0.CO;2-C     Document Type: Article

References (45)

1. S.H. Itzkowitz, M. Yuan, C.K. Montgomery, T. Kjeldsen, H.K. Takahashi, W.L. Bigbee and Y.S. Kim (1989). Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 49, 197-204.
2. S. Hirohashi, H. Clausen, T. Yamada, Y. Shimosato and S. Hakomori (1985). Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen. Proc. Natl. Acad. Sci. USA 82, 7039-7043.
3. H. Takahashi, R. Metoki and S. Hakomori (1988). Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated alpha-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen. Cancer Res. 48, 4361-4367.
4. G.F. Springer (1984). T and Tn, general carcinoma autoantigens. Science 224, 1198-1206.
5. G.F. Springer and P.R. Desai. Pancarcinoma T and Tn epitopes: Autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis, in: Immunodiagnosis of Cancer, 2nd Edition, R.B. Herberman and D.W. Mercer, Eds. p. 587-612, Marcel Dekker, New York, 1990.
6. T. Kjeldsen, H. Clausen, S. Hirohashi, T. Ogawa, H. Iijima and S. Hakomori (1988). Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res. 48, 2214-2220.
7. R. Stein, S. Chen, W. Grossman and M. Goldenberg (1989). Human lung carcinoma monoclonal antibody specific for the Thomsen-Friedenreich antigen. Cancer Res. 49, 32-37.
8. G.F. Springer (1989). Tn epitope (N-acetyl-D-galactosamine-O-serine/threonine) density in primary breast carcinoma: A functional predictor of aggresiveness. Mol. Immunol. 26, 1-5.
9. G.F. Springer, E.V. Chanderasekaran, P.R. Desai and H. Tegtmeyer (1988). Blood group Tn-active macromolecules from human carcinomas and erythrocytes: characterization of and specific reactivity with monoand poly-clonal anti-Tn antibodies induced by various immunogens. Carbohydr. Res. 178, 271-292.
10. J. Huang, J.C. Byrd. B. Siddiki, M. Yuan, E. Lau and Y.S. Kim (1992). Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen. Disease Markers 10, 81-94.
11. N. Barr, C.R. Taylor, T. Young and G.F. Springer (1989). Are pancarcinoma T and Tn differentiation antigens? Cancer 64, 834-841.
12. J.E.S. Hansen, H. Clausen, S.L. Hu, J.O. Nielsen and S. Olofsson (1992). An O-linked carbohydrate neutralization epitope of HIV-1 gp 120 is expressed by HIV-1 env gene recombinant vaccinia virus. Arch. Virol. 126, 11-20.
13. B. Jansson and C.A. Borrebaeck (1992). The human repertoire of antibody specifities against Thomsen-Friedenreich and Tn-carcinoma associated antigens as defined by human monoclonal antibodies. Cancer Immunol. Immunother. 34, 294-298.
14. K.P. O'Boyle, R. Zamore, S. Adluri, A. Cohen, N. Kemeny, S. Welt, K.O. Lloyd, H.F. Oettgen, L.J. Old and P.O. Livingston (1992). Immunization of colorectal cancer patients with modified ovine submaxilary mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn. Cancer Res. 52, 5663-5667.
15. M. Zanetti, G. Lenert and G.F. Springer (1992). Idiotypes of pre-existing human anti-carcinoma anti-T and anti-Tn antibodies. Int. Immunol. 5, 113-119.
16. G.D. MacLean, M. Reddish, R.R. Koganty, T. Wong, S. Gandhi, M. Smolenski, J. Samuel, J.M. Nabholtz and B.M. Longenecker (1993). Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol. Immunother. 36, 215-222.
17. G.F. Springer, P.R. Desai, H. Tegtmeyer, B.D. Spencer and E.F. Scanlon. Pancarcinoma T/Tn antigen detects human carcinoma long before biopsy does and its vaccine prevents breast carcinoma recurrence, in: Specific Immunotherapy of Cancer with Vaccines, Annals of the New York Academy of Sciences, Vol. 690, J.C. Bystryn, S. Ferrone, P. Livingston, Eds, 1993, p. 355-357.
18. T. Toyokuni, S. Hakomori and A.K. Singhal (1994). Synthetic carbohydrate vaccines: Synthesis and immunogenicity of Tn antigen conjugates. Bioorg. Med. Chem. 2, 1119-1132.
19. T. Toyokuni, B. Dean and S. Hakomori (1990). Synthetic vaccines: I. Synthesis of multivalent Tn antigen cluster-lysyllysine conjugates. Tetrahedron Lett. 31, 2673-2676.
20. T. Toyokuni and A.K. Singhal (1995). Synthetic carbohydrate vaccines based on tumour-associated antigens. Chem. Soc. Rev., 231-242.
21. H. Paulsen and J.P. Holck (1982). Synthese der glycopeptide O-β-D-galactopyranosyl-(1 → 3)-O-(2-acetamido-2-desoxy-α-D-galactopyranosyl-(1 → 3)-L-serin und threonin. Carbohydr. Res. 109, 89-107.
22. M. Zheng, M. Gobbo, L. Biondi, F. Filira, S. Hakomori and R. Rocchi (1994). Synthetic immunochemistry of glycohexapeptide analogues characteristic of oncofetal fibronectin. Solid phase synthesis and antigenic activity. Int. J. Peptide Protein Res. 43, 230-238.
23. T. Toyokuni, B. Dean, S. Cai, D. Boivin, S. Hakomori and A.K. Singhal (1994). Synthetic vaccines: Synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins. J. Am. Chem. Soc. 116, 395-396.
24. H. Kunz and K. von dem Bruch (1994). Neoglycoproteins from synthetic glycopeptides. Methods Enzymol. 247, 3-30.
25. T. Norberg, B. Luning and J. Tejbrant (1994). Solid phase synthesis of O-glycopeptides. Methods Enzymol. 247, 87-106.
26. H.G. Garg, K. von dem Bruch and H. Kunz (1994). Developments In the synthesis of glycopeptides containing glycosyl L-asparagine, L-serine, and L-threonine. Adv. Carbohydr. Chem. Biochem. 50, 277-310.
27. M. Meldal. Glycopeptide synthesis, in: Neoglycoconjugates: Preparation and Applications, Y.C. Lee and R.T. Lee, Eds, p. 145-198, Academic Press, San Diego, 1994.
28. S. Bay, R. Lo-Man, E. Osinaga, H. Nakada, C. Leclerc and D. Cantacuzene (1997). Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. J. Peptide Res. 49, 620-625.
29. J.P. Tam (1988). Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA 85, 5409-5413.
30. J.C. Spetzler and J.P. Tam (1995). Unprotected peptides as building blocks for branched peptides and peptide dendrimers. Int. J. Peptide Protein Res. 45, 78-85.
31. J. Shao and J.P. Tam (1995). Unprotected peptides as building blocks for the synthesis of peptide dendrimers with oxime, hydrazone and thiazolldine linkages. J. Am. Chem. Soc. 117, 3893-3899.
32. S. Butz, S. Rawer, W. Rapp and U. Birsner (1994). Immunization and affinity purification of antibodies using resin-immobilized lysine-branched synthetic peptides. Peptide Res. 7, 20-23.
33. A. Basak, A. Boudreault, A. Chen, M. Chrétien, N.G. Seidah and C. Lazure (1995). Application of the multiple antigenic peptides (MAP) strategy to the production of prohormone convertases antibodies: synthesis, characterization and use of 8-branched immunogenic peptides. J. Peptide Sci. 1, 385-395.
34. N.D. Zegers, E. Claassen and W.J.A. Boersma. Multiple antigen peptides for immunization, in: Immunol. Recognit. Peptide Med. Biol., N.D. Zegers, W.J.A. Boersma and E. Claassen, Eds, p. 205-212, CRC, Boca Raton, FL, 1995.
35. J.P. Tam and J.C. Spetzler (1995). Chemoselective approaches to the preparation of peptide dendrimers and branched artificial proteins using unprotected peptides as building blocks. Biomed. Peptide Proteins Nucleic Acids 1, 123-132.
36. R. Quarrell, T.D.W. Claridge, G.W. Weaver and G. Lowe (1996). Structure and properties of Tenta Gel resin beads: implications for combinatorial library chemistry. Mol. Diversity 1, 223-232.
37. G. Barany and RB. Merrifield. Solid-phase peptide synthesis, in: The Peptides. Analysis, Synthesis, Biology, Vol. 2, Part A, E. Gross and J. Meienhofer, Eds, p. 1-284, Academic Press, New York, 1980.
38. E. Kaiser, R.L. Colescott, C.D. Bossinger and P.I. Cook (1970). Color test for the detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem. 34, 595-598.
39. L. Zhang, C. Goldammer, B. Henkel, F. Zuhl, G. Jung and E. Bayer. 'Magic mixture', a powerful solvent system for solid-phase synthesis of 'difficult sequences', in: Innovation and Perspectives in Solid Phase Synthesis. Peptides, Proteins and Nucleic Acids 1993. R. Epton, Ed., p. 711-716. Mayflower Worldwide Ltd., Birmingham, 1994.
40. H. Paulsen, T. Bielfeldt, S. Peters, M. Meldal and K. Bock (1994). New strategy for the solid phase synthesis of O-glycopeptides via 2-azido-glycopeptides. Liebigs Ann. Chem. 369-379.
41. J.P. Tam and Y.A. Lu (1995). Coupling difficulty associated with interchain clustering and phase transition in solid phase peptide synthesis. J. Am. Chem. Soc. 117, 12058-12063.
42. J. Bernillon and J.M. Wallach (1993). Design of a new multiple antigen peptide system, using 9-fluorenyl-methoxycarbonyl (Fmoc) strategy. Biotechnol. Tech. 7, 603-608.
43. M. Pisačka et al. In preparation.
44. J. Ježek, J. Velek, T. Trnka and M. Pisačka. Solid phase synthesis of Tn antigens in both free and immobilized form, in: Innovation and Perspectives in Solid Phase Synthesis and Combinatorial Libraries, 1995, R. Epton, Ed., p. 427-428, Mayflower Scientific, Birmingham, 1997.
45. J. Ježek, J. Velek, T. Trnka, M. Pisačka and F. Mareček. Solid phase synthesis of glycopeptide dendrimers with Tn antigenic structure and their biological activities, in: Peptides 1996, R. Ramage and R Epton, Eds, p. 503-504, Mayflower, London, 1998.